Mexico
· Delayed Price · Currency is MXN Vertex Pharmaceuticals Statistics
Total Valuation
BMV:VRTX has a market cap or net worth of MXN 2.22 trillion. The enterprise value is 2.03 trillion.
| Market Cap | 2.22T |
| Enterprise Value | 2.03T |
Important Dates
The last earnings date was Monday, May 5, 2025.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 256.80M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.20% |
| Shares Change (QoQ) | -0.38% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 256.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 23.43 |
| PS Ratio | 9.77 |
| PB Ratio | 6.57 |
| P/TBV Ratio | 7.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.74, with an EV/FCF ratio of -79.25.
| EV / Earnings | -100.19 |
| EV / Sales | 9.29 |
| EV / EBITDA | 21.74 |
| EV / EBIT | 23.40 |
| EV / FCF | -79.25 |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.65 |
| Quick Ratio | 2.12 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.35 |
| Debt / FCF | -1.32 |
| Interest Coverage | 189.98 |
Financial Efficiency
Return on equity (ROE) is -5.64% and return on invested capital (ROIC) is 14.73%.
| Return on Equity (ROE) | -5.64% |
| Return on Assets (ROA) | 11.77% |
| Return on Invested Capital (ROIC) | 14.73% |
| Return on Capital Employed (ROCE) | 23.08% |
| Revenue Per Employee | 37.19M |
| Profits Per Employee | -3.31M |
| Employee Count | 6,100 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 4.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.73% in the last 52 weeks. The beta is 0.51, so BMV:VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +18.73% |
| 50-Day Moving Average | 9,329.71 |
| 200-Day Moving Average | 7,925.57 |
| Relative Strength Index (RSI) | 34.29 |
| Average Volume (20 Days) | 495 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.25 |
Income Statement
In the last 12 months, BMV:VRTX had revenue of MXN 226.87 billion and -20.21 billion in losses. Loss per share was -78.52.
| Revenue | 226.87B |
| Gross Profit | 120.44B |
| Operating Income | 90.08B |
| Pretax Income | -6.14B |
| Net Income | -20.21B |
| EBITDA | 93.70B |
| EBIT | 90.08B |
| Loss Per Share | -78.52 |
Balance Sheet
The company has 126.75 billion in cash and 33.71 billion in debt, giving a net cash position of 198.43 billion.
| Cash & Cash Equivalents | 126.75B |
| Total Debt | 33.71B |
| Net Cash | 198.43B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 337.17B |
| Book Value Per Share | 1,312.10 |
| Working Capital | 127.24B |
Cash Flow
In the last 12 months, operating cash flow was -20.04 billion and capital expenditures -5.52 billion, giving a free cash flow of -25.55 billion.
| Operating Cash Flow | -20.04B |
| Capital Expenditures | -5.52B |
| Free Cash Flow | -25.55B |
| FCF Per Share | n/a |
Margins
Gross margin is 53.09%, with operating and profit margins of 39.71% and -8.91%.
| Gross Margin | 53.09% |
| Operating Margin | 39.71% |
| Pretax Margin | -2.70% |
| Profit Margin | -8.91% |
| EBITDA Margin | 41.30% |
| EBIT Margin | 39.71% |
| FCF Margin | n/a |
Dividends & Yields
BMV:VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.20% |
| Shareholder Yield | 1.20% |
| Earnings Yield | -0.91% |
| FCF Yield | -1.15% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BMV:VRTX has an Altman Z-Score of 13.24.
| Altman Z-Score | 13.24 |
| Piotroski F-Score | n/a |